ID   SK-RC-54
AC   CVCL_6200
SY   SK RC 54; SKRC-54; RCC 54; RCC54
DR   IARC_TP53; 26510
DR   Wikidata; Q54954602
RX   PubMed=2386958;
RX   PubMed=15026329;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 22,24
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 15.3
ST   D21S11: 29,32
ST   D22S1045: 15,16
ST   D2S1338: 23
ST   D2S441: 11
ST   D3S1358: 14,15
ST   D5S818: 12,14
ST   D7S820: 7,9
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 21,23
ST   Penta D: 11,14
ST   Penta E: 5,12
ST   TH01: 6
ST   TPOX: 12
ST   vWA: 16,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=2386958;
RA   Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J.;
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
//
RX   PubMed=15026329; DOI=10.1158/0008-5472.CAN-03-1541;
RA   Gurova K.V., Hill J.E., Razorenova O.V., Chumakov P.M., Gudkov A.V.;
RT   "p53 pathway in renal cell carcinoma is repressed by a dominant
RT   mechanism.";
RL   Cancer Res. 64:1951-1958(2004).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8; PMCID=PMC5168717;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//